The medication has a wholesale acquisition cost of $1,850 per vial.
BOSTON, - The U.S. Justice Department on Wednesday accused Regeneron Pharmaceuticals , opens new tab of manipulating Medicare's drug-pricing process by inflating the average sales price for its expensive macular degeneration drug Eylea.
The drug, which the Tarrytown, New York-based company began marketing in 2011, is approved by the U.S. Food and Drug Administration for treating conditions including wet age-related macular degeneration, which impairs vision. "By doing so, Regeneron greatly inflated the costs of its drug to Medicare over many years and enhanced its revenues," acting U.S. Attorney Joshua Levy of Massachusetts said in a statement.
پاکستان تازہ ترین خبریں, پاکستان عنوانات
Similar News:آپ اس سے ملتی جلتی خبریں بھی پڑھ سکتے ہیں جو ہم نے دوسرے خبروں کے ذرائع سے جمع کی ہیں۔
– Today’s Dollar Price in PakistanUSD to PKR (Dollar Price in Pakistan Rupee): – The US Dollar to Pakistani Rupee interbank exchange rate is PKR 279 as per P
مزید پڑھ »
– Today’s Dollar Price in PakistanUSD to PKR (Dollar Price in Pakistan Rupee): – The US Dollar to Pakistani Rupee interbank exchange rate is PKR 278.8 as per
مزید پڑھ »
Petrol price in Pakistan increased by Rs9.66 to Rs289.41Gov announced a hike in price of petrol by Rs9.66/litre, but concurrently reduced the price of high-speed diesel (HSD) by Rs3.32/litre
مزید پڑھ »
US Supreme Court abortion pill fight brings claims of distorted scienceMifepristone is taken with another drug called misoprostol to perform medication abortions
مزید پڑھ »
Honda City Price Reduced in Pakistan: Check out the latest price here!Following Kia and Toyota, Honda Atlas Cars Limited has reduced the price of its popular sedan, the Honda City 1.2L, in Pakistan. This price
مزید پڑھ »
Xiaomi market value soars by up to $7.6bn on EV launchFollowing the SU7 launch, other Chinese EV brands with comparable models announced price cuts
مزید پڑھ »